• LAST PRICE
    1.4000
  • TODAY'S CHANGE (%)
    Trending Down-0.0600 (-4.1096%)
  • Bid / Lots
    1.3600/ 4
  • Ask / Lots
    1.4300/ 4
  • Open / Previous Close
    1.4600 / 1.4600
  • Day Range
    Low 1.3600
    High 1.4835
  • 52 Week Range
    Low 1.3600
    High 3.0700
  • Volume
    26,830
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.46
TimeVolumeTXMD
09:32 ET4141.46
09:33 ET11001.45
09:35 ET9151.45
09:51 ET1001.4835
10:02 ET3391.47
10:08 ET1001.47
10:15 ET1001.4543
10:18 ET2901.45
10:31 ET1001.45
10:47 ET6001.4499
11:02 ET29481.45
11:25 ET1541.45
12:01 ET1031.45
12:03 ET6111.43
12:08 ET1001.43
12:33 ET2781.42
12:35 ET37301.42
12:48 ET11921.4
01:11 ET8661.4
01:15 ET23001.41
01:45 ET1801.42
01:51 ET5001.4195
01:54 ET1711.4199
02:05 ET10001.425
02:07 ET13051.4
02:38 ET1001.38
02:43 ET2841.38
03:24 ET10091.38
03:37 ET3581.36
03:44 ET5421.39
03:48 ET1001.4091
04:00 ET2391.4
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTXMD
TherapeuticsMD Inc
16.1M
-4.0x
---
United StatesTLPH
Talphera Inc
11.7M
-1.0x
---
United StatesBQST
BioQuest Corp
10.9M
-19.6x
---
United StatesALID
Allied Corp
5.5M
-0.7x
---
United StatesSYBE
SYBLEU Inc
5.5M
-1.9x
---
United StatesSNBH
Sentient Brands Holdings Inc
5.4M
-5.1x
---
As of 2024-11-18

Company Information

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

Contact Information

Headquarters
951 Yamato Road, Suite 220BOCA RATON, FL, United States 33431
Phone
561-961-1900
Fax
---

Executives

Executive Chairman of the Board
Thomas Thompson
Chief Executive Officer
Marlan Walker
Principal Financial Officer, Principal Accounting Officer
Joseph Ziegler
Independent Director
Cooper Collins
Independent Director
Gail Naughton

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$16.1M
Revenue (TTM)
$1.6M
Shares Outstanding
11.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.14
EPS
$-0.35
Book Value
$2.54
P/E Ratio
-4.0x
Price/Sales (TTM)
10.1
Price/Cash Flow (TTM)
---
Operating Margin
-379.20%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.